Source: International Congress 2017 – GR2 Lung Cancer Grand Round



Rating:

Share or cite this content

Citations should be made in the following way:
Matthew Evison (Manchester, United Kingdom). Pushing the limits, real benefit for the patient ? – a curative treatment approach in an unfit lung cancer patient. International Congress 2017 – GR2 Lung Cancer Grand Round

Member's Comments

No comment yet.

Related content which might interest you: Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables. Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019 Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Source: Eur Respir J 2002; 19: 464-468 Year: 2002 Curative treatment vs. best supportive care in advanced non small cell lung cancer in aged person Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Marginal candidates for lung cancer surgery: is the consensus of real benefit? Source: Annual Congress 2010 - Selection criteria in lung cancer surgery: what really changed? Year: 2010 Some characteristics of patients with lung cancer elected for palliative treatment Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 Does a straight-to-CT pathway improve lung cancer patient waiting times? Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008 Study of patient nominated symptoms and changing symptamatology in patients with lung cancer receiving palliative chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Palliative care or standard chemotherapy in lung cancer patients? Source: Annual Congress 2012 - Ethics Grand Round: an interactive session Year: 2012 Symptomatic benefit of short regimen of palliative radiotherapy for elderly patients with locally advanced non small cell lung cancer Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Prerequisites, potential and limits of thoracic surgery with curative intent for stage III NSCLC Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease Year: 2019 Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT). Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Poor performance status patient in advanced lung cancer: to treat or not to treat? Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat? Year: 2008 Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery: yes, radiation therapy too! Source: Eur Respir J 2016; 48: 276-278 Year: 2016 Measurement of individual quality of life in patients with lung cancer receiving palliative chemotherapy Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 Checkpointinhibition in lung cancer – already standard of care in any line of therapy?  Source: International Congress 2017 – Lung cancer immunotherapy Year: 2017